Literature DB >> 1348044

Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians.

C Bétard1, A M Kessling, M Roy, A Chamberland, S Lussier-Cacan, J Davignon.   

Abstract

Familial hypercholesterolemia (FH), at a prevalence of about 1 in 200 in the French-Canadian population, is caused by a 10-kb deletion in the low-density lipoprotein (LDL) receptor gene in 60% of French-Canadian FH heterozygotes. We genotyped 159 FH patients who carry this common mutation and 221 healthy French-Canadian controls for five DNA restriction fragment length polymorphisms (RFLPs) of the LDL receptor gene. The allele numbers for four of the five RFLPs differed significantly (P less than 0.001) between FH patients and control subjects. Our results suggest that the 10-kb deletion carrier allele is associated with a single haplotype (called the B haplotype). In a family study including a patient homozygous for the 10-kb deletion, we showed that the B haplotype cosegregates with the deletion in affected members and that the B haplotype is also associated with the normal allele in some members of the family. We identified 15 different haplotypes for the normal allele in 10-kb deletion carrier FH heterozygotes. These results offer strong support, at a molecular level, for the hypothesis of a founder effect for the 10-kb deletion in the French-Canadian population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348044     DOI: 10.1007/bf00219339

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  36 in total

1.  Genetics and health care: a paradigm shift.

Authors:  P A Baird
Journal:  Perspect Biol Med       Date:  1990       Impact factor: 1.416

2.  Four DNA polymorphisms in the LDL receptor gene: their genetic relationship and use in the study of variation at the LDL receptor locus.

Authors:  R Taylor; M Jeenah; M Seed; S Humphries
Journal:  J Med Genet       Date:  1988-10       Impact factor: 6.318

3.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

4.  Human LDL receptor gene: two ApaLI RFLPs.

Authors:  E Leitersdorf; H H Hobbs
Journal:  Nucleic Acids Res       Date:  1987-03-25       Impact factor: 16.971

5.  Standardization of immunoassays for the quantitation of plasma Apo B protein.

Authors:  M Rosseneu; N Vinaimont; R Vercaemst; W Dekeersgieter; F Belpaire
Journal:  Anal Biochem       Date:  1981-09-01       Impact factor: 3.365

6.  The Lebanese allele at the low density lipoprotein receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum.

Authors:  M A Lehrman; W J Schneider; M S Brown; C G Davis; A Elhammer; D W Russell; J L Goldstein
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

7.  Haplotypes identified by 10 DNA restriction fragment length polymorphisms at the human low density lipoprotein receptor gene locus.

Authors:  M J Kotze; E Langenhoven; A E Retief; H C Seftel; H E Henderson; H F Weich
Journal:  J Med Genet       Date:  1989-04       Impact factor: 6.318

8.  A RFLP associated with the low-density lipoprotein receptor gene (LDLR).

Authors:  M J Kotze; E Langenhoven; E Dietzsch; A E Retief
Journal:  Nucleic Acids Res       Date:  1987-01-12       Impact factor: 16.971

9.  Homozygous familial hypercholesterolemia among French Canadians in Québec Province.

Authors:  S Moorjani; M Roy; C Gagné; J Davignon; D Brun; M Toussaint; M Lambert; L Campeau; S Blaichman; P Lupien
Journal:  Arteriosclerosis       Date:  1989 Mar-Apr

10.  A host of hypercholesterolaemic homozygotes in South Africa.

Authors:  H C Seftel; S G Baker; M P Sandler; M B Forman; B I Joffe; D Mendelsohn; T Jenkins; C J Mieny
Journal:  Br Med J       Date:  1980-09-06
View more
  11 in total

1.  Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci.

Authors:  John V Raelson; Randall D Little; Andreas Ruether; Hélène Fournier; Bruno Paquin; Paul Van Eerdewegh; W E C Bradley; Pascal Croteau; Quynh Nguyen-Huu; Jonathan Segal; Sophie Debrus; René Allard; Philip Rosenstiel; Andre Franke; Gunnar Jacobs; Susanna Nikolaus; Jean-Michel Vidal; Peter Szego; Nathalie Laplante; Hilary F Clark; René J Paulussen; John W Hooper; Tim P Keith; Abdelmajid Belouchi; Stefan Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

Review 2.  Familial hypercholesterolemia--epidemiology, diagnosis, and screening.

Authors:  Siddharth Singh; Vera Bittner
Journal:  Curr Atheroscler Rep       Date:  2015       Impact factor: 5.113

3.  Growing Pains in Cardiovascular Genetics.

Authors:  Dan M Roden
Journal:  Circulation       Date:  2018-09-18       Impact factor: 29.690

Review 4.  Schizophrenia, psychiatric genetics, and Darwinian psychiatry: an evolutionary framework.

Authors:  Godfrey D Pearlson; Bradley S Folley
Journal:  Schizophr Bull       Date:  2007-11-21       Impact factor: 9.306

5.  Evidence for a cholesterol-lowering gene in a French-Canadian kindred with familial hypercholesterolemia.

Authors:  C Sass; L M Giroux; Y Ma; M Roy; J Lavigne; S Lussier-Cacan; J Davignon; A Minnich
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

6.  Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes.

Authors:  D M Kusters; R Huijgen; J C Defesche; M N Vissers; I Kindt; B A Hutten; J J P Kastelein
Journal:  Neth Heart J       Date:  2011-01-27       Impact factor: 2.380

7.  HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.

Authors:  V Leduc; L De Beaumont; L Théroux; D Dea; P Aisen; R C Petersen; R Dufour; J Poirier
Journal:  Mol Psychiatry       Date:  2014-07-15       Impact factor: 15.992

Review 8.  Prevention of fatal hepatic complication in schistosomiasis by inhibition of CETP.

Authors:  Shinji Yokoyama; Kuniko Okumura-Noji; Rui Lu
Journal:  J Biomed Res       Date:  2015-04-15

Review 9.  HDL Receptor in Schistosoma japonicum Mediating Egg Embryonation: Potential Molecular Basis for High Prevalence of Cholesteryl Ester Transfer Protein Deficiency in East Asia.

Authors:  Shinji Yokoyama
Journal:  Front Cell Dev Biol       Date:  2022-03-17

10.  Saudi Familial Hypercholesterolemia Patients With Rare LDLR Stop Gain Variant Showed Variable Clinical Phenotype and Resistance to Multiple Drug Regimen.

Authors:  Zuhier Ahmed Awan; Omran M Rashidi; Bandar Ali Al-Shehri; Kaiser Jamil; Ramu Elango; Jumana Y Al-Aama; Robert A Hegele; Babajan Banaganapalli; Noor A Shaik
Journal:  Front Med (Lausanne)       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.